E-course: Defining complete response in MIBC after systemic neoadjuvant and adjuvant therapies
In this e-course by the European School of Urology and the EAU Section of Urological Imaging, the international experts will provide the latest updates on imaging and biomarkers for muscle-invasive bladder cancer (MIBC) treatment.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
The management of MIBC is rapidly evolving with the increasing use of neoadjuvant and adjuvant systemic therapies. However, defining a true complete response after treatment remains a major clinical challenge.
In this e-course, international experts will discuss current evidence on MRI and PET imaging, and biomarkers such as ctDNA, to assess treatment response and guide subsequent management in MIBC.
Speakers:
- Prof. Dr. A. Van Der Heijden (NL)
- Prof. V. Panebianco (IT)
- Prof. Dr. D. Oprea-Lager (NL)
- Prof. Dr. A. Heidenreich (DE)
This e-course is brought to you in collaboration with the EAU Section of Urological Imaging.